Vimarsana
Biggest News Aggregation in the World

Memory Ageing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Memory Ageing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Memory Ageing Today - Breaking & Trending Today

New Therapy May Delay Progression of Alzheimer's Disease - Vimarsana News

New Therapy May Delay Progression of Alzheimer's Disease

Alzheimer's Disease (AD) and other dementias cause a heavy economic and public healthcare burden worldwide. The number of people living with dementia continues to increase mainly due to population aging and growth. Current approved treatments for AD are symptomatic and do not appear to affect disease progression. - Click here if this is your press release! - eTurboNews | Trends | Travel News

NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression - Vimarsana News

NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression

/PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association...

Moleac: NeuroAiDII holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression - Vimarsana News

Moleac: NeuroAiDII holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression

SINGAPORE, Jan. 13, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1.

NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression - Vimarsana News

NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression

/PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association...